Effect of Unani formulation in Tinea Corporis

Efficacy of Nuqoo e Mundi(Sphaeranthus indicus) and Roghan e Neem(Azadirachta indica) in Quba [Tinea corporis]

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/044906

Enrollment

Registered

2022-08-25

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Mundi and Neem: Nuqoo e Mundi 7gm in 30 ml of water in the morning empty stomach orally for 28 days Roghan-e-Neem For local application over the lesion twice a day for 28 days Control

Eligibility

Inclusion criteria

Inclusion criteria: Patients age between 18-60 years of all gender Mycological(KOH) confirmed cases of tinea corporis (KOH +ve cases) Patients with 2 years of chronicity of tinea corporis Patients who are willing to sign the consent form for the trial

Exclusion criteria

Exclusion criteria: Age group less than 18 years or more than 60 years Patients with DM HTN renal and hepatic impairement hypersensitivity to drug Patients with severe skin infections Pregnant and lactating mothers Cases other than tinea corporis Patient on corticosteroid treatment

Design outcomes

Primary

Measure	Time frame
KOH examination of skin scrap should be negativeTimepoint: 28 days	—

Secondary

Measure	Time frame
Reduction in subjective parameters will be according to arbitrary grading scale or physicians global assesment scoreTimepoint: 0th 7th 14th 21st 28th 35th day	—

Countries

India

Contacts

Public ContactDr Sayema Khan

Government Unani Medical College and Hospital

drasif.i.siddiqui@gmail.com9986812499

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026